There were also no differences between the groups regarding the time since T2DM diagnosis, the duration of treatment, the type of treatment (oral medications, insulin, or diet-only), the number of medications used, or the presence of T2DM complications (all p > 0.05). The gene discussed is INS; the disease is type 2 diabetes mellitus.